Leishmaniasis – Pakistan
- March 21, 2022
- [rt_reading_time] min read
The number of leishmaniasis patients was expected to rise in coming days due to non-availability of preventive injections.
The WHO and Médecins Sans Frontières (MSF) were contacted for the immediate supply of the Glucontime injections, and they have agreed to extend all-out support.
The health authorities of the districts had been directed to submit the data of patients so that the department could plan effective interventions.Leishmaniasis is a disease caused by parasites and spread by the bite of a certain sandfly. The cutaneous form presents with skin ulcers. Risk factors include poverty, malnutrition, deforestation, and urbanization. Leishmaniasis can be partly prevented by sleeping under nets treated with insecticide and fumigation.
Leishmaniasis occurs in some 98 countries and affects about 2 million people yearly, and causes between 20 and 50 thousand deaths.
Follow us
While you are here, help us with
Access to Essential Drugs
One third of children, women and men have no access to essential medicines, putting lives at risk. Hospitals frequently run out of medicines and other essential supplies. Our Med-Aid program connects hospitals with aid and ensures that they receive exactly what they need.
Access to Diagnostics
Much of today’s innovation is either not reaching or not suitable for people in developing countries.
Data to Improve Health
Faster and reactive systems to help provide lifesaving support to vulnerable communities.
Support our work. It only takes a minute but makes a world of difference!
With your help we can bring modern diagnostics and essential medicines to people in need, track disease outbreaks better and help prevent future pandemics.
You may also be interested these articles
